Literature DB >> 21506822

Incompatibility between miracidia of Schistosoma mansoni and Helisoma duryi occurs at two stages: penetration and intramolluscan establishment.

John T Sullivan1, John T Yeung.   

Abstract

Helisoma spp. snails are not susceptible to infection with miracidia of Schistosoma mansoni because the miracidia do not penetrate them. However, in view of the phylogenetic proximity and histocompatibility between Helisoma spp. and the normal intermediate host, Biomphalaria glabrata , schistosome miracidia conceivably could survive if experimentally introduced into the hemocoel of Helisoma spp. To test this hypothesis, schistosome-susceptible NIH albino B. glabrata, schistosome-resistant Salvador B. glabrata, and Helisoma duryi were injected with miracidia of S. mansoni, and the outcome was followed both by monitoring snails for infection for several weeks and by histological examination at 24 and 48 hr post-injection (PI). Patent infections developed in most NIH albino snails but in none of the Salvador B. glabrata or H. duryi individuals. Histological analysis showed a higher proportion of normal sporocysts in various tissues of NIH albino snails at both time periods relative to Salvador snails, which contained mostly sporocysts undergoing hemocytic encapsulation. In H. duryi , nearly all sporocysts were dead by 48 hr PI.

Entities:  

Mesh:

Year:  2011        PMID: 21506822     DOI: 10.1645/GE-2758.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  2 in total

Review 1.  Digenean-gastropod host associations inform on aspects of specific immunity in snails.

Authors:  C M Adema; E S Loker
Journal:  Dev Comp Immunol       Date:  2014-07-14       Impact factor: 3.636

2.  Potamopyrgus antipodarum as a potential defender against swimmer's itch in European recreational water bodies-experimental study.

Authors:  Anna Marszewska; Anna Cichy; Jana Bulantová; Petr Horák; Elżbieta Żbikowska
Journal:  PeerJ       Date:  2018-06-25       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.